HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juan-Manuel Sancho Selected Research

Oxaliplatin (Eloxatin)

1/2021A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma.
12/2019Overall survival in patients with relapsed/refractory high grade B-cell lymphomas treated with gemcitabine, oxaliplatin with or without rituximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Juan-Manuel Sancho Research Topics

Disease

16Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2024 - 08/2015
13Lymphoma (Lymphomas)
01/2022 - 02/2008
12Neoplasms (Cancer)
01/2022 - 07/2007
10Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2022 - 04/2015
8B-Cell Lymphoma (Lymphoma, B Cell)
04/2024 - 11/2016
5Neutropenia
04/2024 - 08/2017
5Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2022 - 01/2010
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2023 - 09/2022
4Disease Progression
01/2023 - 01/2010
3Leukemia
08/2023 - 03/2006
3Cardiotoxicity
01/2021 - 01/2010
3Multiple Myeloma
11/2018 - 12/2014
2Anemia
04/2024 - 01/2021
2Thrombocytopenia (Thrombopenia)
12/2023 - 01/2021
2Pathologic Complete Response
04/2021 - 02/2007
2HIV Infections (HIV Infection)
04/2015 - 07/2012
2Infections
07/2012 - 10/2008
2Thrombotic Thrombocytopenic Purpura
06/2011 - 06/2006
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2008 - 07/2007
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2008 - 06/2006
2Meningitis
07/2007 - 03/2006
1Asthenia
04/2024
1Nausea
04/2024
1Abdominal Pain (Pain, Abdominal)
04/2024
1Diarrhea
04/2024
1Cytopenia
03/2024
1Exanthema (Rash)
12/2023
1Colitis
12/2023
1Tonsillar Neoplasms
12/2023
1Burkitt Lymphoma (Burkitt's Lymphoma)
08/2023
1COVID-19
01/2022
1Venous Thromboembolism
11/2018
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2018
1Second Primary Neoplasms (Neoplasms, Second)
01/2018
1Rheumatoid Arthritis
08/2017
1Stomatitis
12/2014
1Mucositis
12/2014
1Ewing Sarcoma (Sarcoma, Ewing)
11/2012

Drug/Important Bio-Agent (IBA)

19Rituximab (Mabthera)FDA Link
05/2024 - 01/2010
5Bendamustine HydrochlorideFDA Link
04/2024 - 11/2019
5Prednisone (Sone)FDA LinkGeneric
03/2024 - 02/2007
5Vincristine (Oncovin)FDA LinkGeneric
03/2024 - 02/2007
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2024 - 01/2010
4selinexorIBA
02/2022 - 01/2021
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2016 - 02/2008
3Doxorubicin (Adriamycin)FDA LinkGeneric
03/2024 - 01/2010
3CT-P10IBA
01/2022 - 08/2017
3Cytarabine (Cytosar-U)FDA LinkGeneric
10/2008 - 03/2006
2parsaclisibIBA
04/2024 - 12/2023
2ibrutinibIBA
04/2024 - 09/2022
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2024 - 12/2023
2obinutuzumabIBA
12/2023 - 12/2020
2Agammaglobulinaemia Tyrosine KinaseIBA
10/2023 - 01/2023
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2023 - 10/2008
2Chimeric Antigen ReceptorsIBA
01/2022 - 01/2021
2Monoclonal AntibodiesIBA
08/2021 - 01/2021
2GemcitabineFDA Link
01/2021 - 12/2019
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 12/2019
2liposomal doxorubicin (Doxil)FDA Link
01/2021 - 01/2010
2Biosimilar PharmaceuticalsIBA
01/2021 - 08/2017
2Biomarkers (Surrogate Marker)IBA
12/2020 - 01/2019
2AnthracyclinesIBA
05/2020 - 11/2019
2plerixaforFDA Link
09/2016 - 11/2012
2Methotrexate (Mexate)FDA LinkGeneric
10/2008 - 02/2007
1Phosphatidylinositols (Phosphatidylinositol)IBA
04/2024
1Alanine (L-Alanine)FDA Link
04/2024
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
03/2024
1Alanine Transaminase (SGPT)IBA
12/2023
1brexucabtagene autoleucelIBA
10/2023
1Indicators and Reagents (Reagents)IBA
01/2023
1OF 743IBA
01/2023
1VaccinesIBA
01/2022
1LigandsIBA
08/2021
1pembrolizumabIBA
08/2021
1BI 836826IBA
01/2021
1tisagenlecleucelIBA
01/2021
1GalliumIBA
12/2020
1pixantrone (BBR 2778)IBA
05/2020
1AnthraquinonesIBA
05/2020
13- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA
01/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2019
1Mitoxantrone (Novantrone)FDA LinkGeneric
11/2019
1Lenalidomide (CC 5013)FDA Link
11/2018
1AntigensIBA
11/2016
1Proteins (Proteins, Gene)FDA Link
07/2015
1Melphalan (Alkeran)FDA LinkGeneric
12/2014
1Anti-Bacterial Agents (Antibiotics)IBA
12/2014

Therapy/Procedure

19Therapeutics
05/2024 - 07/2007
8Drug Therapy (Chemotherapy)
12/2020 - 02/2008
4Stem Cell Transplantation
01/2018 - 07/2012
3Salvage Therapy
01/2023 - 01/2017
1Drug Tapering
08/2023
1Precision Medicine
12/2020
1Intravenous Infusions
08/2017
1Radiotherapy
08/2015
1Highly Active Antiretroviral Therapy (HAART)
04/2015
1Cryotherapy (Therapy, Cold)
12/2014
1Hematopoietic Stem Cell Mobilization
11/2012
1Autologous Transplantation
07/2012
1Plasma Exchange
06/2011